Pyxis Oncology Ratios (2024-2025) | PYXS

Ratios Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 97.06%100.00%
EBT Margin -24.80%-640.82%
EBIT Margin -34.71%-700.35%
EBITDA Margin -20.93%-652.77%
Operating Margin -34.71%-700.35%
Net Margin -24.80%-650.85%
FCF Margin -129.73%-612.16%
Efficiency
Assets Average 214.30M201.85M176.25M146.52M129.54M114.41M
Equity Average 176.97M161.74M137.22M111.93M95.37M78.21M
Invested Capital 184.16M169.79M153.68M120.75M103.10M87.64M68.78M
Asset Utilization Ratio 0.090.020.02
Leverage & Solvency
Equity Ratio 0.840.810.790.770.760.710.65
Valuation
Enterprise Value -157.03M-155.72M-144.82M-126.93M-105.43M-88.94M-76.26M
Return Ratios
Return on Sales -0.25%-4.84%-6.51%-34.61%
Return on Capital Employed -0.56%-0.81%-0.95%-1.12%
Return on Invested Capital -1.10%-1.33%
Return on Assets -0.44%-0.65%-0.75%-0.85%
Return on Equity -0.57%-0.86%-1.01%-1.25%